ArticleJACC. Case reports2025
1-Month Relapse of Undifferentiated Sarcoma in the Left Atrium.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cardiac sarcomas are extremely rare. Echocardiography provides initial information about tumor location and size. However, due to the frequent resemblance to benign myxomas or thrombotic formations, the correct diagnosis often requires a multimodal approach. We report a case of undifferentiated cardiac sarcoma in a 46-year-old woman who underwent surgical resection. One month after the operation, echocardiography revealed disease recurrence. The patient underwent chemotherapy and hypofractionated radiotherapy with significant reduction of mass size. Primary cardiac sarcomas may be suspected by multimodality imaging tests, but the definitive diagnosis is histologic. There is still no international agreement about imaging criteria to define these tumors or optimal treatment. Radical surgery is potentially the best therapeutic option, but it is still burdened by high recurrence rates; radiotherapy, chemotherapy and immunotherapy appear promising, especially when used in combination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.